Sat.Aug 31, 2024

article thumbnail

ESC 2024: Study highlights potential for Novartis to differentiate in HF space

Pharmaceutical Technology

There is a strong opportunity in the heart failure (HF) space for new agents that could reduce HF-associated hospitalisations and mortality.

130
130
article thumbnail

Empowering Clinical Research Through Real-World Evidence with Cloudbyz eClinical Suite

Cloudbyz

Cloudbyz’s Clinical Trial Budget Management (CTBM) system is a centralized, automated budgeting solution that helps organizations gain visibility and insight into the financial health of their clinical trials. The solution enables control of all aspects of a study’s budget with a high level of efficiency. The post Empowering Clinical Research Through Real-World Evidence with Cloudbyz eClinical Suite first appeared on CLOUDBYZ.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diabetes duration has minimal impact on SGLT2 inhibitor efficacy, as per new analysis

Pharmaceutical Technology

A meta-analysis has demonstrated consistent efficacy in heart failure outcomes with SGLT2 inhibitors regardless of disease duration.

130
130
article thumbnail

Drug Patent Expirations for the Week of September 1, 2024

Drug Patent Watch

EPIDUO (adapalene; benzoyl peroxide) Galderma labs lp Patent: 7,964,202 Expiration: Sep 1, 2024 See More … Source

Drugs 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model